Method for gene therapy involving suppression of an immune response
US6093699A · kind A · utility
6Cited by
7References
3Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Nov 10, 1994 |
| Grant date | Jul 25, 2000 |
| Priority date | — |
| Expiry date | Nov 10, 2014 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S424/81
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for specifically suppressing the capacity of a mammal receiving gene therapy to mount an immune response to a given expressed gene of the deficient gene in question, which response is caused by the administration of "foreign" DNA encoding an antigenic protein or vectors comprising such DNA for expression of the deficient gene in the patient receiving gene therapy.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.